A detailed history of Wolverine Trading, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wolverine Trading, LLC holds 56,462 shares of BMY stock, worth $2.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,462
Previous 97,350 42.0%
Holding current value
$2.88 Million
Previous $5.28 Million 55.6%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $1.65 Million - $2.17 Million
-40,888 Reduced 42.0%
56,462 $2.34 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $3.42 Million - $3.87 Million
71,188 Added 272.1%
97,350 $5.28 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $3.22 Million - $3.84 Million
-66,410 Reduced 71.74%
26,162 $1.34 Million
Q3 2023

Nov 15, 2023

BUY
$57.89 - $64.73 $1.32 Million - $1.48 Million
22,826 Added 32.73%
92,572 $5.37 Million
Q2 2023

Aug 23, 2023

BUY
$63.71 - $70.74 $4.44 Million - $4.93 Million
69,746 New
69,746 $4.46 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $1.37 Million - $1.6 Million
25,622 Added 63.88%
65,733 $4.11 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $2.47 Million - $2.89 Million
-41,723 Reduced 50.98%
40,111 $2.43 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $3.74 Million - $4.21 Million
-63,040 Reduced 43.51%
81,834 $5.18 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $7.58 Million - $8.59 Million
131,275 Added 965.33%
144,874 $8.97 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $1.11 Million - $1.23 Million
-19,291 Reduced 58.65%
13,599 $815,000
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $3.69 Million - $4.31 Million
-67,253 Reduced 67.16%
32,890 $1.9 Million
Q1 2020

May 11, 2020

SELL
$46.4 - $67.43 $3.22 Million - $4.68 Million
-69,373 Reduced 40.92%
100,143 $5.45 Million
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $1.19 Million - $1.56 Million
-24,269 Reduced 12.52%
169,516 $10.8 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $1.45 Million - $1.72 Million
-33,989 Reduced 14.92%
193,785 $9.73 Million
Q2 2019

Aug 20, 2019

SELL
$44.62 - $49.34 $229,971 - $254,298
-5,154 Reduced 2.21%
227,774 $10.3 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $6.55 Million - $7.81 Million
145,158 Added 165.38%
232,928 $11.1 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $3.47 Million - $4.5 Million
71,230 Added 430.65%
87,770 $4.47 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $3.3 Million - $3.72 Million
-59,827 Reduced 78.34%
16,540 $1.03 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $2.97 Million - $3.42 Million
-49,512 Reduced 39.33%
76,367 $4.83 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $6.63 Million - $7.23 Million
110,641 Added 726.09%
125,879 $7.71 Million
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $841,594 - $971,270
15,238
15,238 $971,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $108B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.